Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2023-12-28 | New | $2,252,517 | $2,252,517 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| Philip Arthur Epstein | Director, Executive |
| Jeffrey Alan Glazer | Director, Executive |
| Ricardo Alberto Hungria | Director |
| Robert Rene Rabalais | Director |
| Jeffrey David Rosenberg | Director |